Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-10

Clinical Trial Update: A Study to Learn About How Well Riociguat Works, How Safe it is and How it is Used Under Real World Conditions in Patients in the United States Who Are Receiving Riociguat for High Blood Pressure in the Arteries That Carry Blood From the Heart to the Lungs (Pulmonary Arterial Hypertension, PAH)

View source ↗

Summary

This completed real-world clinical trial update assesses the effectiveness, safety, and use of riociguat in United States patients with pulmonary arterial hyper…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riociguat (Adempas) (riociguat)

Snippet

Sponsor: Bayer | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED